Literature DB >> 23777886

Intracellular processing of immunostimulatory CpG-siRNA: Toll-like receptor 9 facilitates siRNA dicing and endosomal escape.

Sergey Nechaev1, Chan Gao, Dayson Moreira, Piotr Swiderski, Agnieszka Jozwiak, Claudia M Kowolik, Jiehua Zhou, Brian Armstrong, Andrew Raubitschek, John J Rossi, Marcin Kortylewski.   

Abstract

Dicer-substrate siRNAs equipped with CpG oligodeoxyribonucleotides overcome the major hurdle in cell-specific siRNA delivery. The CpG-siRNA molecules are actively internalized by TLR9+ cells, without the need for transfection reagents, leading to RNA interference both in vitro and in vivo. Here, we elucidate the molecular mechanisms of CpG-siRNA processing in target cells. We show that shortly after uptake into early endosomes (EE), CpG and siRNA parts of the conjugate are uncoupled in the presence of Dicer endonuclease. Diced siRNA molecules are translocated from endosomes to endoplasmic reticulum, where they can interact with the RNA interference machinery. We previously observed that even though TLR9 is not involved in CpG-siRNA uptake, it is indispensable for induction of gene silencing. To explain the role of TLR9 in intracellular processing of CpG-siRNA, we used primary macrophages derived from wild-type and Tlr9-deficient mice. Macrophages lacking TLR9 showed extended endosomal colocalization of CpG and siRNA parts of the conjugate. However, Tlr9 ablation did not interfere with the interaction of CpG-siRNA with Dicer as shown by in situ proximity ligation assay. Using CpG-siRNA labeled with pH-sensitive dye, we finally identified that lack of TLR9 in macrophages resulted in significant retention of the siRNA in endosomes. Thus, TLR9 facilitates the critical step following CpG-siRNA uncoupling, which is cytoplasmic release of the diced siRNA. These findings suggest that the class of immunostimulatory siRNAs may benefit from activation of certain endosomal immune receptors, such as TLR9, in augmented gene silencing and therapeutic efficacy.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CpG; Cytoplasmic release; Dicer; Endosomal escape; TLR9; siRNA

Mesh:

Substances:

Year:  2013        PMID: 23777886      PMCID: PMC3742675          DOI: 10.1016/j.jconrel.2013.06.007

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  43 in total

1.  Specific interference with gene expression induced by long, double-stranded RNA in mouse embryonal teratocarcinoma cell lines.

Authors:  E Billy; V Brondani; H Zhang; U Müller; W Filipowicz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

2.  A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells.

Authors:  Sandip K Datta; Vanessa Redecke; Kiley R Prilliman; Kenji Takabayashi; Maripat Corr; Thomas Tallant; Joseph DiDonato; Roman Dziarski; Shizuo Akira; Stephen P Schoenberger; Eyal Raz
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

Review 3.  Phagosome maturation: aging gracefully.

Authors:  Otilia V Vieira; Roberto J Botelho; Sergio Grinstein
Journal:  Biochem J       Date:  2002-09-15       Impact factor: 3.857

Review 4.  Bidirectional transport along microtubules.

Authors:  Michael A Welte
Journal:  Curr Biol       Date:  2004-07-13       Impact factor: 10.834

Review 5.  Endocytic recycling.

Authors:  Frederick R Maxfield; Timothy E McGraw
Journal:  Nat Rev Mol Cell Biol       Date:  2004-02       Impact factor: 94.444

6.  Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy.

Authors:  Dong-Ho Kim; Mark A Behlke; Scott D Rose; Mi-Sook Chang; Sangdun Choi; John J Rossi
Journal:  Nat Biotechnol       Date:  2004-12-26       Impact factor: 54.908

7.  Ribonuclease activity and RNA binding of recombinant human Dicer.

Authors:  Patrick Provost; David Dishart; Johanne Doucet; David Frendewey; Bengt Samuelsson; Olof Rådmark
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

8.  The collagenous domains of macrophage scavenger receptors and complement component C1q mediate their similar, but not identical, binding specificities for polyanionic ligands.

Authors:  S Acton; D Resnick; M Freeman; Y Ekkel; J Ashkenas; M Krieger
Journal:  J Biol Chem       Date:  1993-02-15       Impact factor: 5.157

9.  TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo.

Authors:  Qifang Zhang; Dewan Md Sakib Hossain; Sergey Nechaev; Anna Kozlowska; Wang Zhang; Yong Liu; Claudia M Kowolik; Piotr Swiderski; John J Rossi; Stephen Forman; Sumanta Pal; Ravi Bhatia; Andrew Raubitschek; Hua Yu; Marcin Kortylewski
Journal:  Blood       Date:  2013-01-03       Impact factor: 22.113

10.  TLR9 signals after translocating from the ER to CpG DNA in the lysosome.

Authors:  Eicke Latz; Annett Schoenemeyer; Alberto Visintin; Katherine A Fitzgerald; Brian G Monks; Cathrine F Knetter; Egil Lien; Nadra J Nilsen; Terje Espevik; Douglas T Golenbock
Journal:  Nat Immunol       Date:  2004-01-11       Impact factor: 25.606

View more
  22 in total

Review 1.  Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities.

Authors:  Marcin Kortylewski; Dayson Moreira
Journal:  Cancer Immunol Immunother       Date:  2017-02-18       Impact factor: 6.968

2.  Dextran functionalization enhances nanoparticle-mediated siRNA delivery and silencing.

Authors:  Daniel Vocelle; Olivia M Chesniak; Amanda P Malefyt; Georgina Comiskey; Kwasi Adu-Berchie; Milton R Smith; Christina Chan; S Patrick Walton
Journal:  Technology (Singap World Sci)       Date:  2016-03-31

3.  The aptamer-siRNA conjugates: reprogramming T cells for cancer therapy.

Authors:  Dewan Md Sakib Hossain; Priyanka Duttagupta; Marcin Kortylewski
Journal:  Ther Deliv       Date:  2015-01

4.  TLR9-Targeted SiRNA Delivery In Vivo.

Authors:  Dewan Md Sakib Hossain; Dayson Moreira; Qifang Zhang; Sergey Nechaev; Piotr Swiderski; Marcin Kortylewski
Journal:  Methods Mol Biol       Date:  2016

5.  How to train your dragon: targeted delivery of microRNA to cancer cells in vivo.

Authors:  Marcin Kortylewski; Sergey Nechaev
Journal:  Mol Ther       Date:  2014-06       Impact factor: 11.454

6.  Functionalized bioengineered spider silk spheres improve nuclease resistance and activity of oligonucleotide therapeutics providing a strategy for cancer treatment.

Authors:  Anna Karolina Kozlowska; Anna Florczak; Maciej Smialek; Ewelina Dondajewska; Andrzej Mackiewicz; Marcin Kortylewski; Hanna Dams-Kozlowska
Journal:  Acta Biomater       Date:  2017-07-08       Impact factor: 8.947

7.  TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapy.

Authors:  Chan Gao; Anna Kozlowska; Sergey Nechaev; Haiqing Li; Qifang Zhang; Dewan M S Hossain; Claudia M Kowolik; Peiguo Chu; Piotr Swiderski; Don J Diamond; Sumanta K Pal; Andrew Raubitschek; Marcin Kortylewski
Journal:  Cancer Res       Date:  2013-10-23       Impact factor: 12.701

8.  Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia.

Authors:  Qifang Zhang; Dewan Md Sakib Hossain; Priyanka Duttagupta; Dayson Moreira; Xingli Zhao; Haejung Won; Ralf Buettner; Sergey Nechaev; Marcin Majka; Bin Zhang; Qi Cai; Piotr Swiderski; Ya-Huei Kuo; Stephen Forman; Guido Marcucci; Marcin Kortylewski
Journal:  Blood       Date:  2016-01-21       Impact factor: 22.113

9.  Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity.

Authors:  Dewan Md Sakib Hossain; Cedric Dos Santos; Qifang Zhang; Anna Kozlowska; Hongjun Liu; Chan Gao; Dayson Moreira; Piotr Swiderski; Agnieszka Jozwiak; Justin Kline; Stephen Forman; Ravi Bhatia; Ya-Huei Kuo; Marcin Kortylewski
Journal:  Blood       Date:  2013-10-29       Impact factor: 22.113

10.  STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers.

Authors:  Dayson Moreira; Tomasz Adamus; Xingli Zhao; Yu-Lin Su; Zhuoran Zhang; Seok Voon White; Piotr Swiderski; Xin Lu; Ronald A DePinho; Sumanta K Pal; Marcin Kortylewski
Journal:  Clin Cancer Res       Date:  2018-10-18       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.